02/18/2025
5:01 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
7:45 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:01 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:01 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:01 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:01 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
3:01 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:01 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:01 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:05 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Zhang Ping (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:05 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for GYRE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/02/2025
3:06 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:01 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:01 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2024
11:15 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form EFFECT | |
11/13/2024
3:05 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
7:45 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
7:31 AM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Ma Songjiang (Filed by)
| Form SC 13D | |
09/06/2024
7:15 AM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Luo Ying (Filed by)
| Form SC 13D | |
08/16/2024
8:13 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:53 PM | Chen Ruoyu (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:56 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Luo Ying (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:58 PM | Eastling Thomas Wilson (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:01 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:05 PM | Carmichael Gordon (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:07 PM | Epstein David M. (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:10 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Parry Renate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:50 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ying Han (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:04 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:23 PM | Epstein David M. (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
3:27 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
4:19 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:41 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form RW | |
07/12/2024
3:42 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form RW | |
07/05/2024
3:45 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
3:45 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
12:18 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
4:56 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
5:00 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:19 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Market down? Do this now. (Ad) During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now, history is repeating itself.
Here's the truth: Tariffs create uncertainty. Uncertainty drives investors to gold. And gold prices rise as a result. It's a cycle that's already beginning again—and it's your chance to profit.
Why wait? Greed isn't always a bad thing—especially when it comes to protecting and growing your wealth. The smartest investors are already moving their money into gold, and you should too. Download your Free 2025 Gold Guide Now |
06/17/2024
3:30 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:00 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
5:19 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
3:51 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024
7:46 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
7:48 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
7:49 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form ARS | |
04/09/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/08/2024
5:03 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
4:40 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
4:27 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
4:35 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
5:42 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
8:00 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
4:03 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:55 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
7:27 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/21/2024
7:31 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:15 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
4:29 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free GYRE Stock Alerts